Lista de obras - Katharina Grabmeier-Pfistershammer

A Single Quantifiable Viral Load Is Predictive of Virological Failure in Human Immunodeficiency Virus (HIV)-Infected Patients on Combination Antiretroviral Therapy: The Austrian HIV Cohort Study

artículo científico publicado en 2016

A comprehensive and quantitative analysis of the major specificities in rabbit antithymocyte globulin preparations

artículo científico publicado en 2013

A homozygous AP3D1 missense variant in patients with sensorineural hearing loss as the leading manifestation

scientific article published in 2022

Antibodies targeting BTLA or TIM-3 enhance HIV-1 specific T cell responses in combination with PD-1 blockade.

artículo científico publicado en 2017

Assessment of costimulation and coinhibition in a triple parameter T cell reporter line: Simultaneous measurement of NF-κB, NFAT and AP-1.

artículo científico publicado en 2016

Association of CMV-Specific T Cell-Mediated Immunity with CMV DNAemia and Development of CMV Disease in HIV-1-Infected Individuals

artículo científico publicado en 2015

B cells sustain inflammation and predict response to immune checkpoint blockade in human melanoma

artículo científico publicado en 2019

Clinical Challenges in the Management of Leishmania/HIV Coinfection in a Nonendemic Area: A Case Report.

artículo científico publicado en 2012

Cobas ampliprep/cobas TaqMan HIV-1 v2.0 assay: consequences at the cohort level

artículo científico publicado en 2013

Differential decline of SARS‐CoV‐2‐specific antibody levels, innate and adaptive immune cells, and shift of Th1/inflammatory to Th2 serum cytokine levels long after first COVID‐19

artículo científico publicado en 2024

Economic burden of late presentation in HIV disease in Austria: a comparison of the initial costs imposed by advanced HIV disease vs. non-late presentation

artículo científico publicado en 2013

Factors Associated with Low-Level Viraemia and Virological Failure: Results from the Austrian HIV Cohort Study

artículo científico publicado en 2015

Five-year on-treatment efficacy of lamivudine-, tenofovir- and tenofovir + emtricitabine-based HAART in HBV-HIV-coinfected patients.

artículo científico publicado en 2012

HIV coreceptor tropism in antiretroviral treatment-naive patients newly diagnosed at a late stage of HIV infection

artículo científico publicado en 2010

Health-related quality of life and severity of fatigue in HIV/HCV co-infected patients before, during, and after antiviral therapy with pegylated interferon plus ribavirin

artículo científico publicado en 2013

High need for MMR vaccination in HIV infected adults in Austria.

artículo científico publicado en 2014

IL28B polymorphism cannot predict response to interferon alpha treatment in patients with melanoma

artículo científico publicado en 2014

Immunogenicity and tolerability after two doses of non-adjuvanted, whole-virion pandemic influenza A (H1N1) vaccine in HIV-infected individuals

artículo científico publicado en 2012

Impact of Early Initiation of Antiretroviral Therapy in Patients with Acute HIV Infection in Vienna, Austria

artículo científico publicado en 2016

Impact of HIV infection and antiretroviral treatment on N-terminal prohormone of brain natriuretic peptide as surrogate of myocardial function.

artículo científico publicado en 2017

Interferon-free regimens improve health-related quality of life and fatigue in HIV/HCV-coinfected patients with advanced liver disease: A retrospective study

artículo científico publicado en 2016

Interferon-free regimens improve portal hypertension and histological necroinflammation in HIV/HCV patients with advanced liver disease

artículo científico publicado en 2016

Interferon-free treatment with sofosbuvir/daclatasvir achieves sustained virologic response in 100% of HIV/hepatitis C virus-coinfected patients with advanced liver disease

artículo científico publicado en 2016

Late versus non-late presentation of HIV/AIDS: an economic impact analysis

artículo científico publicado en 2010

Low immunogenicity of whole virion, verocell-derived, inactivated, pandemic influenza H1N1 vaccine in HIV-infected patients.

artículo científico publicado en 2010

Low seroprotection rate for meningococcus serogroup C in the adult HIV-1-infected population in Austria

scientific article published on 24 October 2019

Low tetanus, diphtheria and acellular pertussis (Tdap) vaccination coverage among HIV infected individuals in Austria.

artículo científico publicado en 2015

Malignant syphilis in a HIV infected patient

artículo científico publicado en 2015

Non-invasive liver fibrosis assessment and HCV treatment initiation within a systematic screening program in HIV/HCV coinfected patients.

artículo científico publicado en 2017

Not All Immune Checkpoints Are Created Equal

artículo científico publicado en 2018

PD-1 Blockade Promotes Emerging Checkpoint Inhibitors in Enhancing T Cell Responses to Allogeneic Dendritic Cells.

artículo científico publicado en 2017

Predictors for and coverage of influenza vaccination among HIV-positive patients: a cross-sectional survey

artículo científico publicado en 2016

Prevalence of Skin-specific Autoantibodies in HIV-infected Patients and Uninfected Controls

artículo científico publicado en 2019

Progress in eradication of HCV in HIV positive patients with significant liver fibrosis in Vienna

artículo científico publicado en 2017

Receptors and ligands implicated in human T cell costimulatory processes

artículo científico publicado en 2009

Response-guided boceprevir-based triple therapy in HIV/HCV-coinfected patients: the HIVCOBOC-RGT study

artículo científico publicado en 2014

Revisiting liver disease progression in HIV/HCV-coinfected patients: the influence of vitamin D, insulin resistance, immune status, IL28B and PNPLA3.

artículo científico publicado en 2014

T cell stimulator cells, an efficient and versatile cellular system to assess the role of costimulatory ligands in the activation of human T cells

artículo científico publicado en 2010

TIM-3 does not act as a receptor for galectin-9.

artículo científico publicado en 2013

The Impact of PNPLA3 rs738409 SNP on Liver Fibrosis Progression, Portal Hypertension and Hepatic Steatosis in HIV/HCV Coinfection

artículo científico publicado en 2015

Therapeutic PD-L1 antibodies are more effective than PD-1 antibodies in blocking PD-1/PD-L1 signaling

artículo científico publicado en 2019

Therapy and prophylaxis of opportunistic infections in HIV-infected patients: a guideline by the German and Austrian AIDS societies (DAIG/ÖAG) (AWMF 055/066)

artículo científico publicado en 2013

To the editor Re: HIV care: A missed opportunity for immunization.

artículo científico publicado en 2016

Treatment intensification with boceprevir in HIV-positive patients with acute HCV-genotype 1 infection at high risk for treatment failure

artículo científico publicado en 2015

Unreported Missense Mutation in the Dimerization Domain of ADA2 Leads to ADA2 Deficiency Associated with Severe Oral Ulcers and Neutropenia in a Female Somalian Patient-Addendum to the Genotype-Phenotype Puzzle

artículo científico publicado en 2019

Viral determinants predicting hepatitis B surface antigen (HBsAg) seroclearance in HIV-/HBV-coinfected patients.

artículo científico publicado en 2013

Lista de obras de Katharina Grabmeier-Pfistershammer

A Single Quantifiable Viral Load Is Predictive of Virological Failure in Human Immunodeficiency Virus (HIV)-Infected Patients on Combination Antiretroviral Therapy: The Austrian HIV Cohort Study

A comprehensive and quantitative analysis of the major specificities in rabbit antithymocyte globulin preparations

A homozygous AP3D1 missense variant in patients with sensorineural hearing loss as the leading manifestation

Antibodies targeting BTLA or TIM-3 enhance HIV-1 specific T cell responses in combination with PD-1 blockade.

Assessment of costimulation and coinhibition in a triple parameter T cell reporter line: Simultaneous measurement of NF-κB, NFAT and AP-1.

Association of CMV-Specific T Cell-Mediated Immunity with CMV DNAemia and Development of CMV Disease in HIV-1-Infected Individuals

B cells sustain inflammation and predict response to immune checkpoint blockade in human melanoma

Clinical Challenges in the Management of Leishmania/HIV Coinfection in a Nonendemic Area: A Case Report.

Cobas ampliprep/cobas TaqMan HIV-1 v2.0 assay: consequences at the cohort level

Differential decline of SARS‐CoV‐2‐specific antibody levels, innate and adaptive immune cells, and shift of Th1/inflammatory to Th2 serum cytokine levels long after first COVID‐19

Economic burden of late presentation in HIV disease in Austria: a comparison of the initial costs imposed by advanced HIV disease vs. non-late presentation

Factors Associated with Low-Level Viraemia and Virological Failure: Results from the Austrian HIV Cohort Study

Five-year on-treatment efficacy of lamivudine-, tenofovir- and tenofovir + emtricitabine-based HAART in HBV-HIV-coinfected patients.

HIV coreceptor tropism in antiretroviral treatment-naive patients newly diagnosed at a late stage of HIV infection

Health-related quality of life and severity of fatigue in HIV/HCV co-infected patients before, during, and after antiviral therapy with pegylated interferon plus ribavirin

High need for MMR vaccination in HIV infected adults in Austria.

IL28B polymorphism cannot predict response to interferon alpha treatment in patients with melanoma

Immunogenicity and tolerability after two doses of non-adjuvanted, whole-virion pandemic influenza A (H1N1) vaccine in HIV-infected individuals

Impact of Early Initiation of Antiretroviral Therapy in Patients with Acute HIV Infection in Vienna, Austria

Impact of HIV infection and antiretroviral treatment on N-terminal prohormone of brain natriuretic peptide as surrogate of myocardial function.

Interferon-free regimens improve health-related quality of life and fatigue in HIV/HCV-coinfected patients with advanced liver disease: A retrospective study

Interferon-free regimens improve portal hypertension and histological necroinflammation in HIV/HCV patients with advanced liver disease

Interferon-free treatment with sofosbuvir/daclatasvir achieves sustained virologic response in 100% of HIV/hepatitis C virus-coinfected patients with advanced liver disease

Late versus non-late presentation of HIV/AIDS: an economic impact analysis

Low immunogenicity of whole virion, verocell-derived, inactivated, pandemic influenza H1N1 vaccine in HIV-infected patients.

Low seroprotection rate for meningococcus serogroup C in the adult HIV-1-infected population in Austria

Low tetanus, diphtheria and acellular pertussis (Tdap) vaccination coverage among HIV infected individuals in Austria.

Malignant syphilis in a HIV infected patient

Non-invasive liver fibrosis assessment and HCV treatment initiation within a systematic screening program in HIV/HCV coinfected patients.

Not All Immune Checkpoints Are Created Equal

PD-1 Blockade Promotes Emerging Checkpoint Inhibitors in Enhancing T Cell Responses to Allogeneic Dendritic Cells.

Predictors for and coverage of influenza vaccination among HIV-positive patients: a cross-sectional survey

Prevalence of Skin-specific Autoantibodies in HIV-infected Patients and Uninfected Controls

Progress in eradication of HCV in HIV positive patients with significant liver fibrosis in Vienna

Receptors and ligands implicated in human T cell costimulatory processes

Response-guided boceprevir-based triple therapy in HIV/HCV-coinfected patients: the HIVCOBOC-RGT study

Revisiting liver disease progression in HIV/HCV-coinfected patients: the influence of vitamin D, insulin resistance, immune status, IL28B and PNPLA3.

T cell stimulator cells, an efficient and versatile cellular system to assess the role of costimulatory ligands in the activation of human T cells

TIM-3 does not act as a receptor for galectin-9.

The Impact of PNPLA3 rs738409 SNP on Liver Fibrosis Progression, Portal Hypertension and Hepatic Steatosis in HIV/HCV Coinfection

Therapeutic PD-L1 antibodies are more effective than PD-1 antibodies in blocking PD-1/PD-L1 signaling

Therapy and prophylaxis of opportunistic infections in HIV-infected patients: a guideline by the German and Austrian AIDS societies (DAIG/ÖAG) (AWMF 055/066)

To the editor Re: HIV care: A missed opportunity for immunization.

Treatment intensification with boceprevir in HIV-positive patients with acute HCV-genotype 1 infection at high risk for treatment failure

Unreported Missense Mutation in the Dimerization Domain of ADA2 Leads to ADA2 Deficiency Associated with Severe Oral Ulcers and Neutropenia in a Female Somalian Patient-Addendum to the Genotype-Phenotype Puzzle

Viral determinants predicting hepatitis B surface antigen (HBsAg) seroclearance in HIV-/HBV-coinfected patients.